Evidence map›Paper›PMID 30141309›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2018

Evaluation of BAX and BCL-2 Gene Expression and Apoptosis Induction in Acute Lymphoblastic Leukemia Cell Line CCRFCEM after High- Dose Prednisolone Treatment

Amin Ghasemi, Taghi Khanzadeh, Milad Zadi Heydarabad, Arash Khorrami, Akram Jahanban Esfahlan, Somayeh Ghavipanjeh, Mahdi Gholipour Belverdi, Saghar Darvishani Fikouhi, Akbar Darbin, Malihe Najafpour and 1 more

Abstract readEvaluation Study
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Identification of Bioactive Compounds inInternational journal of molecular sciences · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Amin GhasemiStudent Research Committee, Maragheh University of Medical Sciences, Maragheh, Iran. Email: Ako.Azimi@gmail.com
Taghi Khanzadeh
Milad Zadi Heydarabad
Arash Khorrami
Akram Jahanban Esfahlan
Somayeh Ghavipanjeh
Mahdi Gholipour Belverdi
Saghar Darvishani Fikouhi
Akbar Darbin
Malihe Najafpour
Ako Azimi
University of Maragheh · IRBiotechnology Research Center · IRTabriz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Glucocorticoids are one of the most important drugs in the treatment of acute lymphoblastic leukemia for children. It is very important to response to glucocorticoid in the prognosis of these patients. Therefore, resistance to treatment is a major problem in lymphoid leukemia cases. In, this study, CCRF-CEM cell line was selected as a chemotherapy-resistant model. The aim of this study was to evaluate the effect of high dose prednisolone on induction of apoptosis and changes in BAX and BCL-2 gene expression at different times. Methods: CCRF-CEM cell lines were grown in standard conditions. Based on previous studies, a dose of 700 μM as subtoxic dose was selected. Changes in gene expression of BAX and BCL-2 were evaluated by using real time PCR techniques. Also stained with annexin V and the induction of apoptosis was assessed by FACS machine. Results: In this study it was found that prednisolone in high doses at different times significantly increased the gene expression of BAX and on the other hand the amount of BCL-2 expression was reduced. Cells that treated for 48 hours had more significant changes in gene expression. Based on flowcytometry data, prednisolone can induce apoptosis in a time dependent manner on this cancerous resistant cell line. Conclusions: Apoptosis induced by high-dose prednisolone in the CCRF-CEM cells, which is almost resistant, and possibly mediated by reducing the expression of BCL-2 and BAX up-regulation.

Indexed as

Antineoplastic Agents, HormonalApoptosisbcl-2-Associated X ProteinGene Expression Regulation, NeoplasticHumansPrecursor Cell Lymphoblastic Leukemia-LymphomaPrednisoloneProto-Oncogene Proteins c-bcl-2Tumor Cells, CulturedAntineoplastic Agents, HormonalBAX protein, humanbcl-2-Associated X ProteinBCL2 protein, humanPrednisoloneProto-Oncogene Proteins c-bcl-2apoptosisBCL-2 associated XBCL-2 geneLeukemiaPrednisolone

Identifiers

PMID30141309
PMCPMC6171400
OpenAlexW2888450412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.